Alterations in T-Cell Transcription Factors and Cytokine Gene Expression in Late-Onset Alzheimer’s Disease

Abstract

Background: Late-onset Alzheimer’s disease (LOAD) is associated with many environmental and genetic factors. The effect of systemic inflammation on the pathogenesis of neurodegenerative diseases such as AD has been strongly suggested. T helper cells (Th) are one of the important components of the immune system and can easily infiltrate the brain in pathological conditions. The development of each Th-subset depends on the production of unique cytokines and their main regulator. Objective: This study aimed to compare the mRNA levels of Th-related genes derived from peripheral blood mononuclear cells of LOAD patients with control. Also, the identification of the most important Th1/Th2 genes and downstream pathways that may be involved in the pathogenesis of AD was followed by computational approaches. Methods: This study invloved 30 patients with LOAD and 30 non-demented controls. The relative expression of T-cell cytokines (IFN-γ, TNF-α, IL-4, and IL-5) and transcription factors (T-bet and GATA-3) were assessed using real-time PCR. Additionally, protein-protein interaction (PPI) was investigated by gene network construction. Results: A significant decrease at T-bet, IFN-γ, TNF-α, and GATA-3 mRNA levels was detected in the LOAD group, compared to the controls. However, there was no significant difference in IL-4 or IL-5 mRNA levels. Network analysis revealed a list of the highly connected protein (hubs) related to mitogen-activated protein kinase (MAPK) signaling and Th17 cell differentiation pathways. Conclusion: The findings point to a molecular dysregulation in Th-related genes, which can promising in the early diagnosis or targeted interventions of AD. Furthermore, the PPI analysis showed that upstream off-target stimulation may involve MAPK cascade activation and Th17 axis induction.

Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview

“…However, yet another review on peripheral IL-1β, IL-6, TNF-α, and CRP found no statistically significant difference between AD patients and controls in any of these markers [ 116 ]. A possible explanation for this discrepancy is that the meta-analysis by Ng et al included far fewer studies than that by Lai et al Still, Nesham et al reported the opposite trend in a study of 60 subjects, in which mRNA levels of IFN-γ and TNF-α in PBMCs of AD subjects were, instead, decreased compared with non-demented controls [ 117 ].…”

Fahr’s disease with neuropsychiatric symptoms and intermittent course: a case report

“…Approximately 40% of Fahr's disease patients initially present with neuropsychiatric features ranging from mild di culties in concentration and memory to changes in personality, behaviors, psychosis, or dementia (10,11). The speci c manifestation depends on the age of disease onset, with schizophreniform psychosis without neurological features being more prevalent in younger individuals (20-40 years) and dementia and movement disorders being common in later-onset cases (mean age of onset at 49 years) (12).…”

Bioinformatics-Based Approach for Exploring the Immune Cell Infiltration Patterns in Alzheimer’s Disease and Determining the Intervention Mechanism of Liuwei Dihuang Pill

“… 61 Moreover, they can play a key role in the activation or inhibition of AD-related signaling pathways. 62 - 64 The KEGG results showed that the pathways of LDP in the treatment of AD were mainly enriched in the B cell receptor-signaling pathway and in HIV-1 and HCMV infections. Studies have shown that activated B cells can not only induce the differentiation of effector T cells and lead to neuroinflammation 65 - 67 but also participate in the pathological process of AD by secreting cytokines and acting on other immune cells (such as macrophages).…”